Abstract: Disclosed herein are compounds of Formula I wherein R1, R2, X, and Y are defined herein. These compounds are type II topoisomerase inhibitors and can be used in methods for treating infections caused by gram-positive pathogens, gram-negative pathogens, and drug-resistant strains thereof.

Abstract: This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Abstract: This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens. The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Abstract: A system and method for geophysical data collection, for use with resistivity and induced polarization. The system and method include the use of a single voltage reference wire to which all voltage recorders or nodes are connected by means of a piercing wire connector, the voltage recorders providing a measurement of the potential voltage between the reference wire and the ground and allowing for calculation of relative voltage potentials between adjacent recorders.

Abstract: Disclosed herein are compounds of Formula I wherein R1, R2, X, and Y are defined herein. These compounds are type II topoisomerase inhibitors and can be used in methods for treating infections caused by gram-positive pathogens, gram-negative pathogens, and drug-resistant strains thereof.

Abstract: A system and method for geophysical data collection, for use with resistivity and induced polarization. The system and method include the use of a single voltage reference wire to which all voltage recorders or nodes are connected by means of a piercing wire connector, the voltage recorders providing a measurement of the potential voltage between the reference wire and the ground and allowing for calculation of relative voltage potentials between adjacent recorders.

Abstract: A system and method for geophysical data collection, for use with resistivity and induced polarization. The system and method include the use of a single voltage reference wire to which all voltage recorders or nodes are connected by means of a piercing wire connector, the voltage recorders providing a measurement of the potential voltage between the reference wire and the ground and allowing for calculation of relative voltage potentials between adjacent recorders.

Abstract: This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Abstract: Disclosed herein are compounds of Formula I wherein R1, R2, X, and Y are defined herein. These compounds are type II topoisomerase inhibitors and can be used in methods for treating infections caused by gram-positive pathogens, gram-negative pathogens, and drug-resistant strains thereof.

Abstract: This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Abstract: A system and method for geophysical data collection, for use with resistivity and induced polarization. The system and method include the use of a single voltage reference wire to which all voltage recorders or nodes are connected by means of a piercing wire connector, the voltage recorders providing a measurement of the potential voltage between the reference wire and the ground and allowing for calculation of relative voltage potentials between adjacent recorders.

Abstract: This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Abstract: This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Abstract: The present invention describes novel anti-bacterial compounds of the formula (I). These compounds are, amongst others, of interest as inhibitors of DNA gyrase and topoisomerases, for example of topoisomerase II and IV.

Abstract: The present invention describes novel anti-bacterial compounds of formula (I). Q-A-R3??(I) These compounds are, amongst others, of interest as inhibitors of DNA gyrase.

Abstract: This invention relates to novel compounds, compositions containing the compounds, that inhibit dipeptidyl peptidase (especially DPP-IV) and neprilysin (NEP, neutral endopeptidase) as well as dipeptidyl peptidase (especially DPP-IV) and angiotensin converting enzyme (ACE) and/or dipeptidyl Peptidase (especially DPP-IV) and vasopeptidases (especially ACE and NEP). These compounds and pharmaceutical compositions thereof are useful for the treatment as well as the prevention of type 2 diabetes mellitus.

Abstract: Polyphenylene ethers produced by an oxidative coupling of a phenol in the presence of an oxygen-containing gas and a metal-amine complex catalyst are freed of catalyst and stabilized against molecular weight loss. Removal of the metal component and molecular weight loss control are effected by contacting the reaction mixture with an aromatic amine plus a metal chelating agent, which stabilizes the intrinsic viscosity of the polyphenylene ether in the reaction mixture. This procedure results in lower catalyst usage and shorter reaction time.